Company Filing History:
Years Active: 2013
Title: Susanne Doris Margit Bökman-Winiwarter: Innovator in Pharmaceutical Chemistry
Introduction
Susanne Doris Margit Bökman-Winiwarter is a notable inventor based in Mölndal, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. Her work is characterized by a focus on treating diseases related to melanin-concentrating hormone.
Latest Patents
Bökman-Winiwarter holds a patent for a compound described as (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone. This patent discloses azetidinyl compounds and their pharmaceutical compositions, which are intended for the treatment or prophylaxis of melanin-concentrating hormone-related diseases or conditions. She has 1 patent to her name, showcasing her innovative approach to drug development.
Career Highlights
Throughout her career, Bökman-Winiwarter has been associated with AstraZeneca AB, a leading global biopharmaceutical company. Her role at AstraZeneca has allowed her to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Bökman-Winiwarter has collaborated with several esteemed colleagues, including Marlene Fredenwall and Carl Anders Hogner. These collaborations have contributed to the advancement of her research and the successful development of new pharmaceutical compounds.
Conclusion
Susanne Doris Margit Bökman-Winiwarter is a prominent figure in pharmaceutical innovation, with a focus on developing treatments for hormone-related conditions. Her contributions to the field are marked by her patent and collaborative efforts, which continue to influence the landscape of medical research.